![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](om6121contents.gif)
Acta Cryst. (2002). E58, o1460-o1462 [ doi:10.1107/S1600536802021748 ]
2(S),6(R)-Dimethyl-4-(4-methoxyphenyl)-5(R)-ethyl-3-cyclohexene-1(S)-carboxylic acid and its enantiomer: potential therapeutic agents for prostate cancer
S. Xie, Y. Hou, C. Y. Meyers and P. D. Robinson
Abstract: The synthesis, isolation, and definitive diasteriomeric characterization of the racemic title compound, C18H24O3, (I), was accomplished. The two enantiomers are hydrogen bonded through their respective carboxylic acid groups, forming an octagonal bridge. A preliminary study indicates that (I) definitely inhibits prostate cancer-cell proliferation.
Online 30 November 2002
Copyright © International Union of Crystallography
IUCr Webmaster